Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 3 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
GSK profit drops in first quarter on higher costs
Digital Journal· 3 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 2 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
The Wall Street Journal· 7 days agoHis lab there found that resveratrol appeared to prolong the lifespan of mice. Sinclair was one of...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 2 days agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Wall Street stocks end mostly down while dollar slides after Fed decision
AFP via Yahoo Finance· 3 days agoWall Street stocks finished a choppy session mostly lower while the dollar retreated Wednesday after...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
WIVB Buffalo· 4 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Competition from 'skinny label' generics saved medicare billions, according to report
Medical Xpress· 1 day agoAn analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that...
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 3 days agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...